Cellromax Science

셀로맥스사이언스 · 471820

Consumer Staples Food & Beverage · KOSDAQ

Small-cap

Market cap US$38.9M (₩53.7B)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$16.1M
▲ +2.6% YoY
Operating profit · FY2025
US$2.1M
▼ −48.5% YoY
Net income · FY2025
US$2.5M
▼ −9.6% YoY

Revenue

  • FY2024US$15.7M
  • FY2025US$16.1M

Operating profit

  • FY2024US$4M
  • FY2025US$2.1M

Net income

  • FY2024US$2.8M
  • FY2025US$2.5M

Key ratios (FY2025)

ROE
7.4%
Debt/Eq
8.5%
Op. margin
12.8%
Net margin
15.6%
Rev. YoY
▲ +2.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.